Drug Discovery · Biotechnology
Relay Therapeutics: Funding & valuation
Relay Therapeutics: 2 money records, each linked to its source.
Data updated Nov 22, 2026 · Back to the company report
Financials
Revenue of $15.4M in 2025. +53.4% on the year before. Net income −$276.5M.
$15.4MRevenue2025 · +53.4%
−$276.5MNet income2025 · +18.1%
Revenue by yearas filed, with the net income
Sources: SEC
Money
Relay Therapeutics: 2 money records, each linked to its source.
$410kCapital expenditureFY2025
Growth rankingsthe yearly lists of the fastest growing companies
#324
From its filingssec.gov ↗
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Capital expenditure | $4.1M | $2M | $410k |
| Stock-based compensation | $86M | $94.1M | $62.4M |
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
